1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Evome Medical Technologies Inc.

Evome Medical Technologies Inc.

LNDZF
Evome Medical Technologies Inc.US flagOther OTC
0.00
USD
- -
- -
5,981.00Market Cap

Total Valuation

Evome Medical Technologies Inc. carries a market capitalization of 5,981.00, placing it among publicly traded companies globally. Its enterprise value stands at 22.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5,981.00
Enterprise Value22.36M

Share Statistics

Evome Medical Technologies Inc. currently has 82.63M shares outstanding.

Shares Outstanding82.63M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.13, and the price-to-book ratio stands at -0.34.

PE RatioN/A
PS Ratio0.13
PB Ratio-0.34
P/TBV Ratio-0.56
P/FCF Ratio1.16
P/OCF Ratio1.17

Enterprise Valuation

EV / Sales0.46
EV / EBITDAN/A
EV / EBITN/A
EV / FCF2.65

Financial Position

Evome Medical Technologies Inc. maintains a current ratio of 0.51, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -509.18, indicating conservative leverage, while an interest coverage ratio of -1.22 demonstrates limited ability to service its debt obligations.

Current Ratio0.51
Quick Ratio0.24
Debt / Equity-509.18
Debt / EBITDA-4.81
Interest Coverage-1.22

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-45.69
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.99

Taxes

Income Tax20,799.00
Effective Tax RateN/A

Stock Price Statistics

Evome Medical Technologies Inc.'s stock has declined approximately -98.33333% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change-98.33333%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Evome Medical Technologies Inc. generated 48.34M in revenue and converted that into -23.53M in net income, yielding earnings per share of -0.26. EBITDA reached -3.63M, while operating income came in at -5.50M.

Revenue48.34M
Gross Profit16.34M
Operating Income-5.50M
Pretax Income-23.51M
Net Income-23.53M
EBITDA-3.63M
EBIT-5.50M
Earnings Per Share (EPS)-0.26

Balance Sheet

Evome Medical Technologies Inc. holds 1.41M in cash and equivalents against 17.47M in total debt, resulting in a net debt position of 11.00M. Total book value stands at -18.67M, with working capital of -16.44M providing operational flexibility.

Cash & Cash Equivalents1.41M
Total Debt17.47M
Net Debt11.00M
Equity (Book Value)-18.67M
Book Value Per Share-0.21
Working Capital-16.44M

Cash Flow

Evome Medical Technologies Inc. produced 5.40M in operating cash flow over the past twelve months. After subtracting -36,075.00 in capital expenditures, free cash flow totaled 5.37M - equivalent to 0.06 per share.

Operating Cash Flow5.40M
Capital Expenditures-36,075.00
Free Cash Flow5.37M
FCF Per Share0.06

Margins

Evome Medical Technologies Inc. operates with a gross margin of 33.80, reflecting its pricing power and cost economics. The operating margin of -11.37 and net profit margin of -48.68 provide insight into operational efficiency.

Gross Margin33.80
Operating Margin-11.37
Pretax Margin-48.64
Profit Margin-48.68
EBITDA Margin-7.51

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield96.33
FCF Yield86.26

Stock Splits

Evome Medical Technologies Inc.'s most recent stock split took place on June 9, 2021 with a 1000:737 split ratio.

Last Split Date6/9/2021
Split Ratio1000:737

Scores

Evome Medical Technologies Inc. posts an Altman Z-Score of -3.24, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.24